EUVIMEDEUVIMED entdecken
Crossref

Silibinin attenuated pseudo‐allergic reactions and mast cell degranulation via PLCγ and PI3K /Akt signaling pathway

Yuejin Wang iD, Shiting Hu, Baowen Dang, Yonghui Zhang, Guodong Zheng, Chenrui Zhao, Yihan Huang, Tao Zhang

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Yuejin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Jiaotong University School of Medicine, Xi'an, China. Hauptthemen laut MEDLINE: Anaphylaxis, Anti-Allergic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Institutional Science Foundation of The First Affiliated Hospital of Xi'an Jiaotong University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaphylaxis is a type of potentially fatal hypersensitivity reaction resulting from the activation of mast cells. Many endogenous or exogenous factors could cause this reaction. Silibinin is the main chemical component of silymarin and has been reported to have pharmacological activities. However, the anti‐allergic reaction effect of silibinin has not yet been investigated. This study aimed to evaluate the effect of silibinin to attenuate pseudo‐allergic reactions in vivo and to investigate the underlying mechanism in vitro. In this study, calcium imaging was used to assess Ca 2+ mobilization. The levels of cytokines and chemokines, released by stimulated mast cells, were measured using enzyme immunoassay kits. The activity of silibinin was evaluated in a mouse model of passive cutaneous anaphylaxis (PCA). Western blotting was used to explore the related molecular signaling pathways. In results, silibinin markedly inhibited mast cell degranulation, calcium mobilization, and preventing the release of cytokines and chemokines in a dose‐dependent manner via the PLCγ and PI3K/Akt signaling pathway. Silibinin also attenuated PCA in a dose‐dependent manner. In summary, silibinin has an anti‐pseudo‐allergic pharmacological activity, which makes it a potential candidate for the development of a novel agent to arrest pseudo‐allergic reactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaphylaxisAnti-Allergic AgentsMiceAnimalsSilybinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCell DegranulationMast CellsCalciumSignal TransductionCytokinesChemokines

Stichwörter der Autor:innen

PI3K/Aktmast cellpseudo-allergysilibinin

Substanzen

SilybinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCalciumCytokinesChemokinesAnti-Allergic Agents

Autor:innen und Institutionen

  • Xi'an Jiaotong University School of Medicine, Xi'an, China.

ORCID-Profile: Yuejin Wang

Förderung

  • Institutional Science Foundation of The First Affiliated Hospital of Xi'an Jiaotong University
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Hu, S., Dang, B., Zhang, Y., Zheng, G., Zhao, C., Huang, Y., & Zhang, T. (2023). Silibinin attenuated pseudo‐allergic reactions and mast cell degranulation via PLCγ and PI3K /Akt signaling pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.7835

Vancouver

Wang Y, Hu S, Dang B, Zhang Y, Zheng G, Zhao C, et al. Silibinin attenuated pseudo‐allergic reactions and mast cell degranulation via PLCγ and PI3K /Akt signaling pathway. Phytotherapy Research. 2023. doi:10.1002/ptr.7835

BibTeX
@article{Wang2023,
  author = {Wang, Yuejin and Hu, Shiting and Dang, Baowen and Zhang, Yonghui and Zheng, Guodong and Zhao, Chenrui and Huang, Yihan and Zhang, Tao},
  title = {Silibinin attenuated pseudo‐allergic reactions and mast cell degranulation via PLCγ and PI3K /Akt signaling pathway},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7835}
}
Kostenlos starten →